# Exploring Hexarelin's Protective Role in Neuroblastoma Cells with SOD1 Mutations

Canonical source: https://retacompare.com/research/exploring-hexarelin-s-protective-role-in-neuroblastoma-cells-with-sod1-mutations

Growth Hormone Peptides · 2023-01-04


    Hexarelin has demonstrated protective effects against oxidative stress in neuroblastoma cells expressing the SOD1-G93A mutation. This finding is particularly relevant in the context of amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease linked to such mutations. Current treatments for ALS are limited to symptomatic relief, highlighting the need for innovative therapeutic strategies.

 What this study examined

This study investigated the potential therapeutic effects of hexarelin, a growth hormone secretagogue (GHS), in human neuroblastoma cells (SH-SY5Y) that express the SOD1-G93A mutated protein. The researchers incubated these cells with hydrogen peroxide (H2O2) to induce oxidative stress, both in the absence and presence of hexarelin at a concentration of 1 µM. The goal was to assess whether hexarelin could mitigate the cytotoxic effects induced by oxidative stress.

 Why it matters for Hexarelin research

The implications of this study are significant for the ongoing research into hexarelin and its potential applications in neurodegenerative diseases like ALS. By demonstrating that hexarelin can protect against H2O2-induced cytotoxicity, the study suggests that GHSs could play a crucial role in developing new neuroprotective strategies. This aligns with the growing interest in GHSs as potential therapeutic agents beyond their traditional uses.

 Key findings

Hexarelin protected SH-SY5Y SOD1 G93A cells from H2O2-induced cytotoxicity.

The protective effect was linked to the activation of molecules regulating apoptosis and promoting cell survival.

Hexarelin was studied alongside another GHS, JMV2894, which also exhibited protective effects.

The study highlights the need for further research to clarify the molecular mechanisms of GHSs.

There is potential for developing GHS-based antioxidant and neuroprotective drugs for ALS therapy.

 How Hexarelin works (background)

Hexarelin is a synthetic peptide that belongs to the class of growth hormone secretagogues. It primarily stimulates the release of growth hormone from the pituitary gland, which can lead to various physiological effects, including increased muscle mass and improved metabolism. In the context of neuroprotection, hexarelin has been noted for its ability to modulate cellular processes related to survival and apoptosis. By activating specific signaling pathways, hexarelin may enhance cellular resilience against oxidative stress, which is a significant factor in the pathogenesis of neurodegenerative diseases like ALS.

 Practical takeaways for researchers

For researchers exploring the therapeutic potential of hexarelin, this study underscores the importance of investigating GHSs in the context of neurodegenerative diseases. The protective effects observed in neuroblastoma cells suggest that further studies could elucidate the mechanisms underlying hexarelin's action. Additionally, researchers should consider the implications of these findings for developing new treatment strategies for ALS and other related conditions. Ongoing research may also explore the combination of hexarelin with other compounds to enhance its neuroprotective effects.

 FAQ

 What is hexarelin used for?

Hexarelin is primarily researched for its ability to stimulate growth hormone release and its potential neuroprotective effects in various models of neurodegeneration.

 How does hexarelin affect neuroblastoma cells?

Hexarelin has been shown to protect neuroblastoma cells expressing the SOD1-G93A mutation from oxidative stress-induced cytotoxicity.

 What are growth hormone secretagogues?

Growth hormone secretagogues are a class of compounds that stimulate the secretion of growth hormone, and they are being investigated for various therapeutic applications, including neuroprotection.

 Source: PubMed · Int J Mol Sci · published 2023-01-04.

## Sources

- PubMed · Int J Mol Sci: https://pubmed.ncbi.nlm.nih.gov/36674509/